Top
Global Peptide Therapeutics Market Research Report 2016
Category : Medical Devices  | Published Date : Nov-2016 | Pages : 115
enquire GET DISCOUNT
Notes:
Production, means the output of Peptide Therapeutics
Revenue, means the sales value of Peptide Therapeutics

This report studies Peptide Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
Amgen
Roche
Sanofi
Takeda Pharmaceutical
Lonza
Novartis
AstraZeneca
Bachem
CordenPharma
Eli Lilly
Ipsen
Merck
Novo Nordisk
PolyPeptide Group
Teva
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Peptide Therapeutics in these regions, from 2011 to 2021 (forecast) , like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Generic Peptide Therapeutics
Branded Peptide Therapeutics
Type III
Split by application, this report focuses on consumption, market share and growth rate of Peptide Therapeutics in each application, can be divided into
Cancer
Cardiovascular
Central Nervous System
Metabolic Disorders
Infection
Hematological Disorders
Gastrointestinal Disorders
Respiratory Disorders
Acromegaly
Other Applications

Table of Contents

Global Peptide Therapeutics Market Research Report 2016
1 Peptide Therapeutics Market Overview
1.1 Product Overview and Scope of Peptide Therapeutics
1.2 Peptide Therapeutics Segment by Type
1.2.1 Global Production Market Share of Peptide Therapeutics by Type in 2015
1.2.2 Generic Peptide Therapeutics
1.2.3 Branded Peptide Therapeutics
1.2.4 Type III
1.3 Peptide Therapeutics Segment by Application
1.3.1 Peptide Therapeutics Consumption Market Share by Application in 2015
1.3.2 Cancer
1.3.3 Cardiovascular
1.3.4 Central Nervous System
1.3.5 Metabolic Disorders
1.3.6 Infection
1.3.7 Hematological Disorders
1.3.8 Gastrointestinal Disorders
1.3.9 Respiratory Disorders
1.3.10 Acromegaly
1.3.11 Other Applications
1.4 Peptide Therapeutics Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Peptide Therapeutics (2011-2021)

2 Global Peptide Therapeutics Market Competition by Manufacturers
2.1 Global Peptide Therapeutics Production and Share by Manufacturers (2015 and 2016)
2.2 Global Peptide Therapeutics Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Peptide Therapeutics Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Peptide Therapeutics Manufacturing Base Distribution, Sales Area and Product Type
2.5 Peptide Therapeutics Market Competitive Situation and Trends
2.5.1 Peptide Therapeutics Market Concentration Rate
2.5.2 Peptide Therapeutics Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Peptide Therapeutics Production, Revenue (Value) by Region (2011-2016)
3.1 Global Peptide Therapeutics Production and Market Share by Region (2011-2016)
3.2 Global Peptide Therapeutics Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Peptide Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Peptide Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Peptide Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Peptide Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Peptide Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Peptide Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Peptide Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Peptide Therapeutics Supply (Production) , Consumption, Export, Import by Regions (2011-2016)
4.1 Global Peptide Therapeutics Consumption by Regions (2011-2016)
4.2 North America Peptide Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Peptide Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Peptide Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Peptide Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Peptide Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Peptide Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Peptide Therapeutics Production, Revenue (Value) , Price Trend by Type
5.1 Global Peptide Therapeutics Production and Market Share by Type (2011-2016)
5.2 Global Peptide Therapeutics Revenue and Market Share by Type (2011-2016)
5.3 Global Peptide Therapeutics Price by Type (2011-2016)
5.4 Global Peptide Therapeutics Production Growth by Type (2011-2016)

6 Global Peptide Therapeutics Market Analysis by Application
6.1 Global Peptide Therapeutics Consumption and Market Share by Application (2011-2016)
6.2 Global Peptide Therapeutics Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Peptide Therapeutics Manufacturers Profiles/Analysis
7.1 Amgen
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Peptide Therapeutics Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Amgen Peptide Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Roche
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Peptide Therapeutics Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Roche Peptide Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Sanofi
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Peptide Therapeutics Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Sanofi Peptide Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Takeda Pharmaceutical
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Peptide Therapeutics Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Takeda Pharmaceutical Peptide Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Lonza
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Peptide Therapeutics Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Lonza Peptide Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Novartis
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Peptide Therapeutics Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Novartis Peptide Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 AstraZeneca
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Peptide Therapeutics Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 AstraZeneca Peptide Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Bachem
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Peptide Therapeutics Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 Bachem Peptide Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 CordenPharma
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Peptide Therapeutics Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 CordenPharma Peptide Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 Eli Lilly
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 Peptide Therapeutics Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 Eli Lilly Peptide Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview
7.11 Ipsen
7.12 Merck
7.13 Novo Nordisk
7.14 PolyPeptide Group
7.15 Teva

8 Peptide Therapeutics Manufacturing Cost Analysis
8.1 Peptide Therapeutics Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Peptide Therapeutics

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Peptide Therapeutics Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Peptide Therapeutics Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Peptide Therapeutics Market Forecast (2016-2021)
12.1 Global Peptide Therapeutics Production, Revenue Forecast (2016-2021)
12.2 Global Peptide Therapeutics Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Peptide Therapeutics Production Forecast by Type (2016-2021)
12.4 Global Peptide Therapeutics Consumption Forecast by Application (2016-2021)
12.5 Peptide Therapeutics Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer


List of Tables and Figures

Figure Picture of Peptide Therapeutics
Figure Global Production Market Share of Peptide Therapeutics by Type in 2015
Figure Product Picture of Generic Peptide Therapeutics
Table Major Manufacturers of Generic Peptide Therapeutics
Figure Product Picture of Branded Peptide Therapeutics
Table Major Manufacturers of Branded Peptide Therapeutics
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Peptide Therapeutics Consumption Market Share by Application in 2015
Figure Cancer Examples
Figure Cardiovascular Examples
Figure Central Nervous System Examples
Figure Metabolic Disorders Examples
Figure Infection Examples
Figure Hematological Disorders Examples
Figure Gastrointestinal Disorders Examples
Figure Respiratory Disorders Examples
Figure Acromegaly Examples
Figure Other Applications Examples
Figure North America Peptide Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Peptide Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Peptide Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Peptide Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Peptide Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Peptide Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Peptide Therapeutics Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Peptide Therapeutics Production of Key Manufacturers (2015 and 2016)
Table Global Peptide Therapeutics Production Share by Manufacturers (2015 and 2016)
Figure 2015 Peptide Therapeutics Production Share by Manufacturers
Figure 2016 Peptide Therapeutics Production Share by Manufacturers
Table Global Peptide Therapeutics Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Peptide Therapeutics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Peptide Therapeutics Revenue Share by Manufacturers
Table 2016 Global Peptide Therapeutics Revenue Share by Manufacturers
Table Global Market Peptide Therapeutics Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Peptide Therapeutics Average Price of Key Manufacturers in 2015
Table Manufacturers Peptide Therapeutics Manufacturing Base Distribution and Sales Area
Table Manufacturers Peptide Therapeutics Product Type
Figure Peptide Therapeutics Market Share of Top 3 Manufacturers
Figure Peptide Therapeutics Market Share of Top 5 Manufacturers
Table Global Peptide Therapeutics Production by Regions (2011-2016)
Figure Global Peptide Therapeutics Production and Market Share by Regions (2011-2016)
Figure Global Peptide Therapeutics Production Market Share by Regions (2011-2016)
Figure 2015 Global Peptide Therapeutics Production Market Share by Regions
Table Global Peptide Therapeutics Revenue by Regions (2011-2016)
Table Global Peptide Therapeutics Revenue Market Share by Regions (2011-2016)
Table 2015 Global Peptide Therapeutics Revenue Market Share by Regions
Table Global Peptide Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Peptide Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Peptide Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table China Peptide Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Peptide Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Peptide Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table India Peptide Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Peptide Therapeutics Consumption Market by Regions (2011-2016)
Table Global Peptide Therapeutics Consumption Market Share by Regions (2011-2016)
Figure Global Peptide Therapeutics Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Peptide Therapeutics Consumption Market Share by Regions
Table North America Peptide Therapeutics Production, Consumption, Import & Export (2011-2016)
Table Europe Peptide Therapeutics Production, Consumption, Import & Export (2011-2016)
Table China Peptide Therapeutics Production, Consumption, Import & Export (2011-2016)
Table Japan Peptide Therapeutics Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Peptide Therapeutics Production, Consumption, Import & Export (2011-2016)
Table India Peptide Therapeutics Production, Consumption, Import & Export (2011-2016)
Table Global Peptide Therapeutics Production by Type (2011-2016)
Table Global Peptide Therapeutics Production Share by Type (2011-2016)
Figure Production Market Share of Peptide Therapeutics by Type (2011-2016)
Figure 2015 Production Market Share of Peptide Therapeutics by Type
Table Global Peptide Therapeutics Revenue by Type (2011-2016)
Table Global Peptide Therapeutics Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Peptide Therapeutics by Type (2011-2016)
Figure 2015 Revenue Market Share of Peptide Therapeutics by Type
Table Global Peptide Therapeutics Price by Type (2011-2016)
Figure Global Peptide Therapeutics Production Growth by Type (2011-2016)
Table Global Peptide Therapeutics Consumption by Application (2011-2016)
Table Global Peptide Therapeutics Consumption Market Share by Application (2011-2016)
Figure Global Peptide Therapeutics Consumption Market Share by Application in 2015
Table Global Peptide Therapeutics Consumption Growth Rate by Application (2011-2016)
Figure Global Peptide Therapeutics Consumption Growth Rate by Application (2011-2016)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Peptide Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Peptide Therapeutics Market Share (2011-2016)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Peptide Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Peptide Therapeutics Market Share (2011-2016)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Peptide Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Peptide Therapeutics Market Share (2011-2016)
Table Takeda Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Pharmaceutical Peptide Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Takeda Pharmaceutical Peptide Therapeutics Market Share (2011-2016)
Table Lonza Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lonza Peptide Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Lonza Peptide Therapeutics Market Share (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Peptide Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Peptide Therapeutics Market Share (2011-2016)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Peptide Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca Peptide Therapeutics Market Share (2011-2016)
Table Bachem Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bachem Peptide Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bachem Peptide Therapeutics Market Share (2011-2016)
Table CordenPharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CordenPharma Peptide Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure CordenPharma Peptide Therapeutics Market Share (2011-2016)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Peptide Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly Peptide Therapeutics Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Peptide Therapeutics
Figure Manufacturing Process Analysis of Peptide Therapeutics
Figure Peptide Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Peptide Therapeutics Major Manufacturers in 2015
Table Major Buyers of Peptide Therapeutics
Table Distributors/Traders List
Figure Global Peptide Therapeutics Production and Growth Rate Forecast (2016-2021)
Figure Global Peptide Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Table Global Peptide Therapeutics Production Forecast by Regions (2016-2021)
Table Global Peptide Therapeutics Consumption Forecast by Regions (2016-2021)
Table Global Peptide Therapeutics Production Forecast by Type (2016-2021)
Table Global Peptide Therapeutics Consumption Forecast by Application (2016-2021)
...
Publisher Name : QYResearch

SIMILAR MARKET STUDIES

Please Select Format
Single User: US $ 2900
Enterprise User: US $ 5800

NEED MORE INFORMATION
Contact us
Call us +1-971-202-1575
--- or ---
help@bigmarketresearch.com
WHY BIG MARKET RESEARCH
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.
Top